Compare SXT & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXT | HAE |
|---|---|---|
| Founded | 1882 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | N/A | 1991 |
| Metric | SXT | HAE |
|---|---|---|
| Price | $90.68 | $83.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $110.00 | $79.67 |
| AVG Volume (30 Days) | 283.7K | ★ 1.0M |
| Earning Date | 10-31-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.77% | N/A |
| EPS Growth | ★ 56.32 | 42.54 |
| EPS | 3.27 | ★ 3.44 |
| Revenue | ★ $1,595,084,000.00 | $1,327,850,000.00 |
| Revenue This Year | $4.80 | N/A |
| Revenue Next Year | $5.94 | $6.01 |
| P/E Ratio | $28.25 | ★ $24.43 |
| Revenue Growth | ★ 4.25 | N/A |
| 52 Week Low | $66.15 | $47.32 |
| 52 Week High | $121.54 | $85.23 |
| Indicator | SXT | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 38.75 | 84.77 |
| Support Level | $92.41 | $80.05 |
| Resistance Level | $96.77 | $85.23 |
| Average True Range (ATR) | 2.30 | 2.05 |
| MACD | -0.36 | -0.21 |
| Stochastic Oscillator | 0.46 | 82.33 |
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are; Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.